Novel Genetic Variant of a Class B G Protein-Coupled Receptor Reveals a Role for Adrenomedullin in Human Fertility

le Hay, Debbie L.
Foilsithe in ACS Pharmacol Transl Sci (2018)

Structure–function relationships of the N-terminus of receptor activity-modifying proteins

le Qi, Tao, Hay, Debbie L
Foilsithe 2010

Reply to comment on: A second trigeminal CGRP receptor: function and expression of the AMY1 receptor

le Walker, Christopher S., Hay, Debbie L.
Foilsithe in Ann Clin Transl Neurol (2016)

Secretin family (Class B) G protein-coupled receptors – from molecular to clinical perspectives

le Poyner, David R, Hay, Debbie L
Foilsithe 2012

Amylin structure–function relationships and receptor pharmacology: implications for amylin mimetic drug development

le Bower, Rebekah L, Hay, Debbie L
Foilsithe in Br J Pharmacol (2016)

RAMPs (Receptor-Activity Modifying Proteins): New Insights and Roles

le Hay, Debbie L., Pioszak, Augen A.
Foilsithe in Annu Rev Pharmacol Toxicol (2015)

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

le Pioszak, Augen A., Hay, Debbie L.
Foilsithe in Adv Pharmacol (2020)

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYI...

le Lee, Sang-Min, Hay, Debbie L., Pioszak, Augen A.
Foilsithe in J Biol Chem (2016)

Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYI...

le Lee, Sang-Min, Hay, Debbie L., Pioszak, Augen A.
Foilsithe in J Biol Chem (2016)

Agonist bias and agonist‐dependent antagonism at corticotrophin releasing factor receptors

le Tasma, Zoe, Wills, Peter, Hay, Debbie L., Walker, Christopher S.
Foilsithe in Pharmacol Res Perspect (2020)

Antagonism of CGRP Signaling by Rimegepant at Two Receptors

le Pan, Kylie S., Siow, Andrew, Hay, Debbie L., Walker, Christopher S.
Foilsithe in Front Pharmacol (2020)

Characterization of the Structure of RAMP1 by Mutagenesis and Molecular Modeling

le Simms, John, Hay, Debbie L., Wheatley, Mark, Poyner, David R.
Foilsithe 2006

The pharmacology of Adrenomedullin 2/Intermedin

le Hong, Yanguo, Hay, Debbie L, Quirion, Remi, Poyner, David R
Foilsithe 2012

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

le Hay, Debbie L, Garelja, Michael L, Poyner, David R, Walker, Christopher S
Foilsithe in Br J Pharmacol (2017)

Differential activation of G-proteins by μ-opioid receptor agonists

le Saidak, Zuzana, Blake-Palmer, Katherine, Hay, Debbie L, Northup, John K, Glass, Michelle
Foilsithe 2006

The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling

le Kuwasako, Kenji, Hay, Debbie L, Nagata, Sayaka, Hikosaka, Tomomi, Kitamura, Kazuo, Kato, Johji
Foilsithe 2012

Analysis of Amylin Consensus Sequences Suggests that Human Amylin is Not Optimized to Minimize Amyloid Formation and Provides Clues to Factors that Modulate Amyloidogenicity

le Noh, Daeun, Bower, Rebekah L, Hay, Debbie L, Zhyvoloup, Alexander, Raleigh, Daniel P
Foilsithe in ACS Chem Biol (2020)

Structure–activity relationships for α-calcitonin gene-related peptide

le Watkins, Harriet A, Rathbone, Dan L, Barwell, James, Hay, Debbie L, Poyner, David R
Foilsithe 2013

CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured

le Walker, Christopher S, Raddant, Ann C, Woolley, Michael J, Russo, Andrew F, Hay, Debbie L
Foilsithe in Cephalalgia (2017)

Probing the Mechanism of Receptor Activity–Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Pept...

le Booe, Jason M., Warner, Margaret L., Roehrkasse, Amanda M., Hay, Debbie L., Pioszak, Augen A.
Foilsithe in Mol Pharmacol (2018)